These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
677 related items for PubMed ID: 12773976
1. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Gunji Y, Kobayashi S, Hayashi H, Ochiai T. Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976 [Abstract] [Full Text] [Related]
2. Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma. Zhao Y, Jiang Y, Wang R, Zheng X, Wang X, Jin B, Lu Y, Qiao T, Hong L, Fan D. Ann Surg Oncol; 2007 Sep; 14(9):2621-7. PubMed ID: 17570016 [Abstract] [Full Text] [Related]
3. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC. Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449 [Abstract] [Full Text] [Related]
4. [Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma]. Ikeda K, Terashima M, Ishida K, Okamoto K, Suzuki S, Murakami K, Ohtsu T, Suzuki K, Niitsu Y, Obonai H. Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):677-82. PubMed ID: 3355186 [Abstract] [Full Text] [Related]
5. [Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer]. Mao YS, Zhang DC, Zhao XH, Wang LJ, Qi J, Li XX. Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):457-60. PubMed ID: 14575569 [Abstract] [Full Text] [Related]
6. Squamous cell carcinoma-antigen messenger RNA level in peripheral blood predicts recurrence after resection in patients with esophageal squamous cell carcinoma. Honma H, Kanda T, Ito H, Wakai T, Nakagawa S, Ohashi M, Koyama Y, Valera VA, Akazawa K, Hatakeyama K. Surgery; 2006 May; 139(5):678-85. PubMed ID: 16701102 [Abstract] [Full Text] [Related]
7. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma. Picardo AL, Diez M, Torres A, Maestro M, Ortega D, Hernando F, Gómez A, Garcia-Asenjo J, Balibrea JL. Cancer; 1996 Mar 15; 77(6):1066-72. PubMed ID: 8635125 [Abstract] [Full Text] [Related]
8. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis? Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Van de Vijver MJ, Fleuren GJ, Trimbos JB. Gynecol Oncol; 2000 Apr 15; 77(1):164-70. PubMed ID: 10739706 [Abstract] [Full Text] [Related]
9. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix. Huang EY, Hsu HC, Sun LM, Chanchien CC, Lin H, Chen HC, Tseng CW, Ou YC, Chang HY, Fang FM, Huang YJ, Wang CY, Lu HM, Tsai CC, Ma YY, Fu HC, Wang YM, Wang CJ. Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):1105-13. PubMed ID: 20932670 [Abstract] [Full Text] [Related]
10. Prognostic significance of serum squamous cell carcinoma antigen in surgically treated lung cancer. Takeuchi S, Nonaka M, Kadokura M, Takaba T. Ann Thorac Cardiovasc Surg; 2003 Apr 15; 9(2):98-104. PubMed ID: 12732086 [Abstract] [Full Text] [Related]
11. Serum cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as a prognostic tumor marker in patients with esophageal squamous cell carcinoma. Nabeya Y, Shimada H, Okazumi S, Matsubara H, Gunji Y, Suzuki T, Ochiai T. Cancer; 2002 Feb 15; 94(4):940-9. PubMed ID: 11920462 [Abstract] [Full Text] [Related]
12. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients. Mroczko B, Kozłowski M, Groblewska M, Łukaszewicz M, Nikliński J, Jelski W, Laudański J, Chyczewski L, Szmitkowski M. Clin Chim Acta; 2008 Mar 15; 389(1-2):61-6. PubMed ID: 18155162 [Abstract] [Full Text] [Related]
13. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Aoki T, Sugaya M, Miyazawa Y, Hayashi H, Miyazaki S, Ochiai T. J Surg Oncol; 2003 Aug 15; 83(4):248-52. PubMed ID: 12884238 [Abstract] [Full Text] [Related]
14. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer. van de Lande J, Davelaar EM, von Mensdorff-Pouilly S, Water TJ, Berkhof J, van Baal WM, Kenemans P, Verheijen RH. Gynecol Oncol; 2009 Jan 15; 112(1):119-25. PubMed ID: 19007978 [Abstract] [Full Text] [Related]
15. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung]. Zeng L. Zhonghua Wai Ke Za Zhi; 1993 Mar 15; 31(3):143-5. PubMed ID: 8223022 [Abstract] [Full Text] [Related]
16. The prognostic factors after radical esophagectomy for esophageal cancer with positive preoperative CEA. Takemura M, Osugi H, Takada N, Okuda E, Ueno M, Kinoshita H. Hepatogastroenterology; 2004 Mar 15; 51(55):159-62. PubMed ID: 15011854 [Abstract] [Full Text] [Related]
17. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer. Nakashima S, Natsugoe S, Matsumoto M, Miyazono F, Nakajo A, Uchikura K, Tokuda K, Ishigami S, Baba M, Takao S, Aikou T. Surgery; 2003 Feb 15; 133(2):162-9. PubMed ID: 12605177 [Abstract] [Full Text] [Related]
18. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. Shimada H, Takeda A, Arima M, Okazumi S, Matsubara H, Nabeya Y, Funami Y, Hayashi H, Gunji Y, Suzuki T, Kobayashi S, Ochiai T. Cancer; 2000 Oct 15; 89(8):1677-83. PubMed ID: 11042560 [Abstract] [Full Text] [Related]
19. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer. Reesink-Peters N, van der Velden J, Ten Hoor KA, Boezen HM, de Vries EG, Schilthuis MS, Mourits MJ, Nijman HW, Aalders JG, Hollema H, Pras E, Duk JM, van der Zee AG. J Clin Oncol; 2005 Mar 01; 23(7):1455-62. PubMed ID: 15735121 [Abstract] [Full Text] [Related]
20. Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Kadomatsu K, Muramatsu T, Ikematsu S, Sakuma S, Ochiai T. Oncol Rep; 2003 Mar 01; 10(2):411-4. PubMed ID: 12579281 [Abstract] [Full Text] [Related] Page: [Next] [New Search]